Evidence map›Paper›PMID 25689563›Full record

Trial reportMarine drugs2015

Effects of n-3 polyunsaturated fatty acids (ω-3) supplementation on some cardiovascular risk factors with a ketogenic Mediterranean diet.

Antonio Paoli, Tatiana Moro, Gerardo Bosco, Antonino Bianco, Keith A Grimaldi, Enrico Camporesi, Devanand Mangar

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Marine drugs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Antonio PaoliDepartment of Biomedical Sciences, University of Padova, 35131 Padova, Italy. antonio.paoli@unipd.it.
Tatiana MoroDepartment of Biomedical Sciences, University of Padova, 35131 Padova, Italy. tatiana.moro.phd@gmail.com.
Gerardo BoscoDepartment of Biomedical Sciences, University of Padova, 35131 Padova, Italy. gerardo.bosco@unipd.it.
Antonino BiancoSport and Exercise Sciences Research Unit, University of Palermo, 90144 Palermo, Italy. antonino.bianco@unipa.it.
Keith A GrimaldiBiomedical Engineering Laboratory, Institute of Communication and Computer Systems, National Technical University of Athens, Athens 15773, Greece. keith.grimaldi@gmail.com.
Enrico CamporesiDepartment of Surgery, University of South Florida, Tampa, FL 33620, USA. dmangar1@gmail.com.
Devanand MangarTEAMHealth, Tampa, FL 33606, USA. dmangar1@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundthe ketogenic diet (KD) has become a widely used nutritional approach for weight loss. Some of the KD's positive effects on metabolism and cardiovascular risk factors are similar to those seen after n-3 polyunsaturated fatty acids (ω-3) supplementation. We hypothesized that a ketogenic Mediterranean diet with phytoextracts combined with ω-3 supplementation may have increased positive effects on cardiovascular risk factors and inflammation.

methodsWe analyzed 34 male overweight subjects; aged between 25 and 65 years who were overall healthy apart from overweight. The subjects followed a ketogenic diet protocol for four weeks; with (KDO3) or without (KD) ω-3 supplementation.

resultsAll subjects experienced a significant loss of body weight and body fat and there was no significant differences between treatment (body weight: KD-4.7 kg, KDO3-4.03 kg, body fat KD-5.41 kg, KDO3-5.86 kg). There were also significant decreases in total cholesterol, LDL-c, and glucose levels. Triglycerides and insulin levels decreased more in KDO3 vs. KD subjects, with a significant difference. All the investigated inflammatory cytokines (IL-1β, IL-6, TNF-α) decreased significantly in KDO3 subjects whilst only TNF-α showed a significant decrease in KD subjects over the 12 month study period. No significant changes were observed in anti-inflammatory cytokines (IL-10 and IL-1Ra), creatinine, urea and uric acid. Adiponectin increased significantly only in the KDO3 group.

conclusionsω-3 supplementation improved the positive effects of a ketogenic Mediterranean diet with phytoextracts on some cardiovascular/metabolic risk factors and inflammatory state.

Indexed as

Dietary SupplementsDiet, KetogenicDiet, MediterraneanAdiposityAdultAgedBlood GlucoseCardiovascular DiseasesCholesterol, LDLCytokinesFatty Acids, Omega-3HumansInsulinMaleMiddle AgedOverweightBlood GlucoseCholesterol, LDLCytokinesFatty Acids, Omega-3InsulinPlant ExtractsTriglycerides

Identifiers

PMID25689563
PMCPMC4344614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.